Join 1,500 infusion professionals in Austin, TX, March 23-27 for the industry’s leading education and networking event. The NHIA Annual Conference is the ideal event for infusion professionals or those seeking opportunities in the industry to come together, earn CE or CME, and explore the latest trends in offering home-based services.
Join the discussion and get insight from home & alternate site infusion professionals from across the industry. Whether you are looking for clinical guidance, operations advice, reimbursement tips or anything else—the NHIA Community has you covered.
NHIA’s Sterile Compounding ACT is the definitive training program for Sterile Compounding competency, including what you need to know about the revised USP General Chapter <797>.
The National Home Infusion Foundation’s (NHIF) Status at Discharge Benchmarking initiative is based on the need for research that evaluates the safety of home infusion services and aims to understand why patients discontinue their home infusion service.
On Tuesday, September 19, 2023, the House Energy & Commerce Health Subcommittee held a legislative hearing, “Examining Policies to Improve Seniors’ Access to Innovative Drugs, Medical Devices, and Technology.” Home infusion was discussed at least 3 distinct times throughout the hearing, with a consensus that Medicare needs to improve beneficiary access to home infusion services.
NHIA submitted comments on a CMS PFS proposed rule (CMS-1784-P) that would affect Medicare classification and coverage of self-administered drugs, certain biologics and coding and billing requirements related to the use of single dose containers and drug waste.
NHIA responded to an FDA request for comment on “Increasing Patient Access to At-Home Use Medical Technologies,” applauding the agency for recognizing the importance of facilitating access to care in the home.
NHIA submitted comments to CMS on the proposed 2024 home health payment rule. CMS did not mention the HIT services benefit in its 2024 rulemaking, however, NHIA believes it is important to continue advocating on behalf of Medicare beneficiaries to improve access to home infusion services.
On Friday June 30, 2023, CMS released proposed updates to the Medicare Home Health Prospective Payment System for CY 2024. The proposed home health rule does not address home infusion therapy (HIT) services other than to describe the potential interaction with the new Home IVIG Items and Service benefit, which replaces the IVIG demonstration starting on January 1, 2024.
The National Home Infusion Association (NHIA) applaudes the introduction of bipartisan legislation in the U.S. Senate that will ensure Medicare patients can receive the intravenous (IV) medications they need while at home.
The National Home Infusion Association (NHIA) is pleased to hold its second annual one-day Payor Summit. The event, designed to bring together representatives from commercial health insurance plans with home and specialty infusion leaders, will take place August 23, 2023 in Dallas, TX.
